Novo Nordisk Launches Wegovy® in Hong Kong for Weight Management

Novo Nordisk Launches Wegovy® in Hong Kong for Weight Management

Wegovy® (semaglutide) is a once-weekly injectable prescription medicine used in combination with a reduced calorie diet and increased physical activity for adults and adolescents aged 12 years old or above with obesity or adults with overweight in...

Fibronostics Acquires Stone Clinical Laboratories to Advance MASH/MASLD Diagnostics

Fibronostics Acquires Stone Clinical Laboratories to Advance MASH/MASLD Diagnostics

Acquisition expands U.S. lab operations and accelerates innovation in non-invasive diagnostics for metabolic and liver diseases. NEW ORLEANS, Oct. 27, 2025 /PRNewswire/ -- Fibronostics, a global leader in non-invasive diagnostics for metabolic and...

menu
menu